Влияние повышенной массы тела и ожирения на частоту гинекологической патологии, течение родов, послеродовый период и состояние новорожденных

Карахалис Л.Ю., Могилина М.Н. Влияние повышенной массы тела и ожирения на частоту гинекологической патологии, течение родов, послеродовый период и состояние новорожденных. Гинекология. 2016; 18 (6): 67–70.

________________________________________________

Karakhalis L.Yu., Mogilina M.N. Effect of increased body weight and obesity on the incidence of gynecological pathology, during childbirth, postnatal period and the state of newborns. Gynecology. 2016; 18 (6): 67–70.

Читать PDF

Аннотация

Повышенная масса тела и ожирение влияют на частоту гинекологической патологии, развитие детей, рост эстрогензависимых заболеваний. Рассмотрены вопросы профилактики послеродовых осложнений у женщин с избыточной массой тела и ожирением посредством применения современных дезогестрелсодержащих контрацептивов.

Ключевые слова: повышенная масса тела и ожирение, профилактика заболеваний у детей, контрацепция.

________________________________________________

Increased body weight and obesity affect the incidence of gynecological diseases, the development of children, the growth of estrogen-dependent diseases. The issues of prevention of obstetric complications in women with overweight and obesity through the use of modern desogestrel-containing contraceptives.

Key words: increased weight and obesity, prevention, contraception.

Полный текст

Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью Авторизуйтесь или зарегистрируйтесь.

Список литературы

1. Панькив В.И. Ожирение. Междунар. эндокринологический журн. 2013; 5 (53): 28. / Pan'kiv V.I. Ozhirenie. Mezhdunar. endokrinologicheskii zhurn. 2013; 5 (53): 28.
2. World Health Organization. Obesity and overweight. Newsletter 2014; 311.
3. Meat consumption providing a surplus energy in modern diet contributes to obesity prevalence: an ecological analysis. BMS Nutrition 2016. DOI: 10.1186/s40795-016-0063-9.
4. Kanagalingam MG, Forouhi NG, Greer IA, Sattar N. Changes in booking body mass index over a decade: retrospective analysis. from a Glasgow Maternity Hospital. Bjog 2005; 112: 1431–3.
5. www.who.int/ru/
6. Engeland A, Bjorge T, Tverdal A, Sogaard AJ. Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology 2004; 15: 79–85.
7. Rittmaster RS, Deshwal N, Lehman L. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome. J Clin Endocrinol Metab 1993; 76: 1295–300.
8. Douchi T, Kuwahata R, Yamamoto S et al. Relationship of upper body obesity to menstrual disorders. Acta Obstet Gynecol Scand 2002; 81: 147–50.
9. Balen AH, Dresner M, Scott EM, Drife JO. Should obese women with polycystic ovary syndrome receive treatment for infertility? (Editorial). Br Med J 2006; 332: 434–5.
10. Farquhar CM, Gillett WR. Prioritizing for fertility treatments – should a high BMI exclude treatment? (Commentary). BJOG 2006; 113: 1107–9.
11. Nelson SM, Fleming RF. The preconceptual contraception paradigm: obesity and infertility. Hum Reprod 2007; 22: 912–5.
12. Kubo Ai et al. Associations Between Maternal Pregravid Obesity and Gestational Diabetes and the Timing of Pubarche in Daughters. Am J Epidemiol 2016. DOI: 10.1093/aje/kww006.

________________________________________________

1. Pan'kiv V.I. Ozhirenie. Mezhdunar. endokrinologicheskii zhurn. 2013; 5 (53): 28.
2. World Health Organization. Obesity and overweight. Newsletter 2014; 311.
3. Meat consumption providing a surplus energy in modern diet contributes to obesity prevalence: an ecological analysis. BMS Nutrition 2016. DOI: 10.1186/s40795-016-0063-9.
4. Kanagalingam MG, Forouhi NG, Greer IA, Sattar N. Changes in booking body mass index over a decade: retrospective analysis. from a Glasgow Maternity Hospital. Bjog 2005; 112: 1431–3.
5. www.who.int/ru/
6. Engeland A, Bjorge T, Tverdal A, Sogaard AJ. Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology 2004; 15: 79–85.
7. Rittmaster RS, Deshwal N, Lehman L. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome. J Clin Endocrinol Metab 1993; 76: 1295–300.
8. Douchi T, Kuwahata R, Yamamoto S et al. Relationship of upper body obesity to menstrual disorders. Acta Obstet Gynecol Scand 2002; 81: 147–50.
9. Balen AH, Dresner M, Scott EM, Drife JO. Should obese women with polycystic ovary syndrome receive treatment for infertility? (Editorial). Br Med J 2006; 332: 434–5.
10. Farquhar CM, Gillett WR. Prioritizing for fertility treatments – should a high BMI exclude treatment? (Commentary). BJOG 2006; 113: 1107–9.
11. Nelson SM, Fleming RF. The preconceptual contraception paradigm: obesity and infertility. Hum Reprod 2007; 22: 912–5.
12. Kubo Ai et al. Associations Between Maternal Pregravid Obesity and Gestational Diabetes and the Timing of Pubarche in Daughters.
Am J Epidemiol 2016. DOI: 10.1093/aje/kww006.

Авторы

Л.Ю.Карахалис*, М.Н.Могилина

ФГБОУ ВО Кубанский государственный медицинский университет Минздрава России.
350063, Россия, Краснодар, ул. Седина, д. 4
*lomela@mail.ru

________________________________________________

L.Yu.Karakhalis*, M.N.Mogilina

Kuban State Medical University of the Ministry of Health of the Russian Federation. 350063, Russian Federation, Krasnodar, ul. Sedina, d. 4
*lomela@mail.ru

Назад к списку

Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.